Dr. Kenneth Anderson graduated from Johns Hopkins Medical School, trained in internal medicine at John’s Hopkins Hospital, and completed hematology, medical oncology, and tumor immunology training at the Dana-Farber Cancer Institute.
He is the Kraft Family Professor of Medicine at Harvard Medical School and serves as Chief of the Division of Hematologic Neoplasia and Director of the Jerome Upper Multiple Myeloma Center. He also serves as Vice Chair of the Joint Program in Transfusion Medicine at Dana-Farber Cancer Institute, chair of the NCCN Multiple Myeloma Clinical Practice Guidelines Committee, a Cancer and Leukemia Group B Principal Investigator, on the Board of Scientific Advisor of the International Myeloma Foundation, on the Board of Directors and Chair of the Scientific Advisory Board of the Multiple Myeloma Research Foundation, and he is on the Board of Directors and Chair of the Leadership Committee of the Multiple Myeloma Research Consortium.
Dr. Anderson is a Doris Duke Distinguished Clinical Research Scientist and has had long-term RO-i, PO-i, and SPORE NIH funding. His numerous awards include the 2001 Charles C. Lund Award of the American Red Cross Blood Services, the 2003 Waldenstroms award for research in plasma cell dyscrasias, the 2004 Johnson & Johnson Focused Giving Award for Setting New Directions in Science and Technology, and the 2005 Third Annual International Myeloma Foundation Robert A. Kyle Lifetime Achievement Award. His paradigm for identifying and validating targets in the myeloma cell and its bone marrow milieu has already provided novel therapies and offers great promise to improve patient outcome in hematologic malignancies and solid tumors.